Fundraising Fox

BIOS Health

YC W17 ↗

Cambridge, GB · 45 employees · 5 known investors

bios.health ↗

BIOS develops neural digital therapy technology to deliver treatments for neurological conditions. The company combines neural engineering with AI and machine learning to improve healthcare outcomes and restore patient control over bodily function.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesArtificial IntelligenceNeurotechnologyin /company@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (W17)

OAOliver Armitage
Oliver ArmitageinFounder
EHEmil Hewage
Emil HewageinFounder/Director

Investors · 5

Fifty YearsSan Francisco · $250K – $2M
Heuristic Capital PartnersSanta Clara
Kern Venture GroupBakersfield
The Venture CollectiveMiami Beach · $100K – $2M
Y CombinatorSan Francisco · $500K

Companies House · registry record

View on Companies House ↗
Registered name
BIOS HEALTH LTD
Company number
09575301
Status
Active
Company type
Private limited company
Incorporated
5 May 2015
Registered office
8 Bateman Mews, Cambridge, CB2 1NN
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Previous names
CAMBRIDGE BIO-AUGMENTATION SYSTEMS LTD (2015–2019)
Accounts
last made up to 31 Dec 2024 · next due 30 Sept 2026
Confirmation statement
last made up to 5 May 2026 · next due 19 May 2027

Current officers · 2

  • Krishna Kumar Gupta — director, appointed 5 Dec 2024
  • Cambridge Applied Research — corporate director, appointed 5 May 2015

Source: Companies House public register · retrieved 24 Jul 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news